Browse all articles >
Uncovering the MET-TRIB3-FOXO1 axis: A Novel Target in MET-driven Hepatocellular Carcinoma
Targeting CD36 to reinvigorate CD8+ T Cells in early-stage hepatocellular carcinoma
Grading severity of microvascular invasion in hepatocellular carcinoma: More details, more significance2025 January;31(1)
Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma2023 October;29(4)
Recent advances in the management of hepatocellular carcinoma2024 January;30(1)